XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 25, 2022
Dec. 26, 2021
Cash flows from operating activities      
Net earnings (loss) $ (1,487,800,000) $ 203,000,000.0 $ 435,300,000
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation of property, plant and equipment 127,700,000 127,300,000 163,300,000
Loss on disposal of business 539,000,000.0 22,100,000 108,800,000
Impairment of goodwill 1,191,200,000 0 0
Impairment of intangibles and production assets 116,000,000.0 281,000,000.0 0
Loss on Discovery investment 0 0 74,100,000
Fair value adjustment on Discovery Option 0 0 (20,100,000)
Inventory obsolescence 91,200,000 45,200,000 8,400,000
Amortization of intangible assets 83,000,000.0 105,300,000 116,800,000
Program cost amortization 448,900,000 555,500,000 628,600,000
Deferred income taxes (243,500,000) (130,100,000) 36,000,000.0
Stock-based compensation 72,400,000 83,400,000 97,800,000
Other non-cash items (6,100,000) 3,200,000 (1,500,000)
Changes in operating assets and liabilities, net of acquired and disposed balances:      
Decrease (increase) in accounts receivable 15,500,000 339,600,000 (159,500,000)
Decrease (increase) in inventories 257,100,000 (184,700,000) (182,300,000)
Decrease (increase) in prepaid expenses and other current assets 34,700,000 17,000,000.0 (30,600,000)
Program spend, net (408,000,000.0) (767,700,000) (697,300,000)
(Decrease) increase in accounts payable and accrued liabilities (109,700,000) (278,700,000) 313,200,000
Change in net deemed repatriation tax (34,400,000) (18,400,000) (18,400,000)
Other 38,400,000 (30,100,000) (54,700,000)
Net cash provided by operating activities 725,600,000 372,900,000 817,900,000
Cash flows from investing activities      
Additions to property, plant and equipment (209,300,000) (174,200,000) (132,700,000)
Investments and acquisitions, net of cash acquired 0 (146,300,000) 0
Proceeds from sale of business, net of cash transferred 329,600,000 0 378,500,000
Other (2,700,000) 7,500,000 (3,800,000)
Net cash provided (utilized) by investing activities 117,600,000 (313,000,000.0) 242,000,000.0
Cash flows from financing activities      
Proceeds from borrowings 2,600,000 3,800,000 144,000,000.0
Repayments of borrowings (359,600,000) (206,000,000.0) (1,220,100,000)
Net (repayments) proceeds of other short-term borrowings (41,600,000) 141,700,000 (5,600,000)
Purchases of common stock 0 (125,000,000.0) 0
Stock-based compensation transactions 0 74,200,000 30,600,000
Dividends paid (388,000,000.0) (385,300,000) (374,500,000)
Payments related to tax withholding for share-based compensation (16,800,000) (24,000,000.0) (13,700,000)
Debt extinguishment costs 0 0 (9,100,000)
Other (14,700,000) (32,700,000) (11,400,000)
Net cash utilized by financing activities (818,100,000) (553,300,000) (1,459,800,000)
Effect of exchange rate changes on cash 7,200,000 (12,700,000) (30,600,000)
Increase (decrease) in cash, cash equivalents and restricted cash 32,300,000 (506,100,000) (430,500,000)
Cash, cash equivalents and restricted cash at beginning of year 513,100,000 1,019,200,000 1,449,700,000
Cash, cash equivalents and restricted cash at end of year 545,400,000 513,100,000 1,019,200,000
Supplemental information      
Interest paid 179,000,000.0 161,700,000 171,900,000
Income taxes paid $ 119,800,000 $ 177,200,000 $ 160,500,000